Literature DB >> 12788332

Alcohol and withdrawal: from animal research to clinical issues.

Ph De Witte1, E Pinto, M Ansseau, P Verbanck.   

Abstract

The withdrawal syndrome in alcohol-dependent patients appears to be a major stressful event whose intensity increases with repetition of detoxifications according to a kindling process. Disturbances in the balance between excitatory and inhibitory neural processes are reflected in a perturbed physical state while disturbances in the balance between positive and negative reinforcements are reflected in a perturbed mood state. Our purpose is to link the different behavioral outcomes occurring during withdrawal with specific biological brain mechanisms from the animal to the human being. Better understanding of the various biological mechanisms underlying withdrawal from alcohol will be the key to design and to apply appropriate pharmaceutical management, together with appropriate therapy aimed at inducing protracted abstinence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788332     DOI: 10.1016/s0149-7634(03)00030-7

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  51 in total

1.  Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.

Authors:  John C Umhau; Reza Momenan; Melanie L Schwandt; Erick Singley; Mariel Lifshitz; Linda Doty; Lauren J Adams; Valentina Vengeliene; Rainer Spanagel; Yan Zhang; Jun Shen; David T George; Daniel Hommer; Markus Heilig
Journal:  Arch Gen Psychiatry       Date:  2010-10

2.  Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study.

Authors:  Ralitza Gueorguieva; Ran Wu; Dennis Donovan; Bruce J Rounsaville; David Couper; John H Krystal; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2010-12-08       Impact factor: 3.455

Review 3.  Aspects of the homeostaic plasticity of GABAA receptor-mediated inhibition.

Authors:  Istvan Mody
Journal:  J Physiol       Date:  2004-11-04       Impact factor: 5.182

Review 4.  Polyvagal Theory and developmental psychopathology: emotion dysregulation and conduct problems from preschool to adolescence.

Authors:  Theodore P Beauchaine; Lisa Gatzke-Kopp; Hilary K Mead
Journal:  Biol Psychol       Date:  2006-10-12       Impact factor: 3.251

5.  Role of altered structure and function of NMDA receptors in development of alcohol dependence.

Authors:  József Nagy; Sándor Kolok; András Boros; Péter Dezso
Journal:  Curr Neuropharmacol       Date:  2005-10       Impact factor: 7.363

Review 6.  The genetics of alcoholism.

Authors:  David Stacey; Toni-Kim Clarke; Gunter Schumann
Journal:  Curr Psychiatry Rep       Date:  2009-10       Impact factor: 5.285

7.  Attenuation of ethanol withdrawal by ceftriaxone-induced upregulation of glutamate transporter EAAT2.

Authors:  Osama A Abulseoud; Ulas M Camsari; Christina L Ruby; Aimen Kasasbeh; Sun Choi; Doo-Sup Choi
Journal:  Neuropsychopharmacology       Date:  2014-01-23       Impact factor: 7.853

8.  Sequence variations of the human MPDZ gene and association with alcoholism in subjects with European ancestry.

Authors:  Victor M Karpyak; Jeong-Hyun Kim; Joanna M Biernacka; Eric D Wieben; David A Mrazek; John L Black; Doo-Sup Choi
Journal:  Alcohol Clin Exp Res       Date:  2009-01-21       Impact factor: 3.455

9.  Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol.

Authors:  Marina Rubio; Douglas McHugh; Javier Fernández-Ruiz; Heather Bradshaw; J Michael Walker
Journal:  Neurosci Lett       Date:  2007-06-02       Impact factor: 3.046

10.  Effects of nitric oxide synthase inhibition in the dorsolateral periaqueductal gray matter on ethanol withdrawal-induced anxiety-like behavior in rats.

Authors:  Vivian Taciany Bonassoli; Ewandro Braz Contardi; Humberto Milani; Rúbia Maria Weffort de Oliveira
Journal:  Psychopharmacology (Berl)       Date:  2013-03-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.